Esperion Therapeutics
ESPR
ESPR
132 hedge funds and large institutions have $241M invested in Esperion Therapeutics in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 28 closing their positions.
Holders
132
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
29
Increased
43
Reduced
30
Closed
28
Calls
$7.04M
Puts
$1.17M
Net Calls
+$5.87M
Net Calls Change
+$4.26M
Top Buyers
| 1 |
WA
1
Wasatch Advisors
Salt Lake City,
Utah
|
$37.8M |
| 2 |
2
BlackRock
New York
|
$17.5M |
| 3 |
3
Millennium Management
New York
|
$5.79M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$20.8M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$3.5M |
Top Sellers
| 1 |
DM
1
Deerfield Management
New York
|
$0 |
| 2 |
CH
2
CVI Holdings
Wilmington,
Delaware
|
$0 |
| 3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$0 |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$2.96M |
